Lectures 1-5 Flashcards

0
Q

Enhanced digestive elimination

A

Osmotic purgatives

SORBITOL 70%, 240 ML
t 1.3h
MAGNESIUM CITRAT 20-30g sol 10%
t 4h
MAGNESIUM SULPHATE sol 10% 15-20g
t 17h
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Enterohepatic recirculation compounds

A
 Chloralhydrat
 Phenotyasines
 Colchicine
 Phenitoyn
 Digitoxin
 Salicylates
 Digoxin
 Isoniaside
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug removal

A

 Ph modification
 Forced diuresis
 Repetead activated charcoal
 Extracorporeal techniques: haemodyalisis,
haemoperfusion, plasmapheresis, exchange
transfusion
 Hyperoxibarism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ACID DIURESIS

-> phencyclidine, amphetamine overdose

A

optimal urine pH < 5.5

ascorbic acid 0.5-2.0 g iv
NH4Cl 75mg/kg/24 h, po/iv (2%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ALKALINE DIURESIS

-> salicylate, barbiturate overdose

A

optimal urine pH >7.5

bicarbonate 1-2 mEq/kg
acetazolamide 500 mg

  • Unless managed carefully, potential for fluid overload, electrolyte abnormalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

FORCED DIURESIS

A

Fluids overload

  • Diuretics: furosemide, manitol
  • Urinary flow: 3-5 ml/kg/h
  • Indications: barbiturates, salicylates,
    amphetamines
  • Unless managed carefully, potential for
    fluid overload, electrolyte abnormalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HEMODIALYSIS

A

Severe poisoning with:

(MW<500, high solubility, low binding plasmatic albumines)

  1. salicylate
  2. lithium
  3. alcohols: methanol, isopropranolol, ethylene glycol
  4. phenobarbitone
  5. chloralhidrat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HEMOPERFUSION

A

Severe poisoning with:

  1. short acting barbiturates
  2. sedatives and hipnothics
  3. phenitoyn
  4. choramphenicol
  5. salicylate
  6. paraquat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antidote for Paracetamol

A

Acetylcysteine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antidote for ethanol

A

NO antidote ‼️

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antidote for Organophosphates

A

Diazepam, Atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antidote for benzodiazepines

A

Flumazenil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antidote for Arsenic

A

Dimercaprol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antidote for iron

A

Deferoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antidote for beta adrenergic agonists

A

Beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antidote for Cyanide

A

Amyl Nitrite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug induced hyperthermia

A

Dantrolene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Antidote for HF, fluorides, oxalates

A

Calcium gluconate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Antidote for beta blocker

A

Glucagon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Antidote for ethylene glycol

A

4 methylpyrazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Antidote for Methaemoglobinemia

A

Methylene blue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Antidote for Opiates

A

Naloxone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Antidote for Organophosphorus insecticides

A

Obidoxime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Antidote for Carbon monoxide, Cyanide

A

Oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Antidote for Organophosphorus compounds

A

Pralidoxime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Antidote for central anticholinergic syndrome

A

Physostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Antidote for Isoniazid, Hydralazine

A

Pyridoxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Antidote for Copper

A

Penicillamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Antidote for Cyanide

A

Sodium nitrite, Sodium Thiosulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Antidote for Heparin

A

Protamine Sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Antidote for Salicylate, tricyclic antidepressants

A

Sodium Bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Emetics

A

Apomorphine, Ipecacuanha

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Alkalinize blood and urine

A

Sodium Bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Cathartics and sol for whole gut lavage

A

Sorbitol, Mannitol
Magnesium citrate, mag sulfate
Bicarbonates, Sodium Sulfates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Prevents absorbtion in gut:

A
Activated charcoal (for adsorbable poison)
Starch (for iodine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Prevents skin absorbtion/damage

A

Calcium gluconate gel - for hydrofluoric acid

Polyethylene glycol - for phenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Anti-foaming agent

A

Dimethicone (soaps, shampoos)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Dystonia

A

Benztropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Medication for: Psychotic with severe agitation

A

Chlorpromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Medication for: Acute allergic reaction, mucosal edema, laryngeal edema, bronhoconstriction

A

Corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Medication for: Convulsions, Anxiety, excitation, muscular hypertonia

A

Diazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Medication for: myocardial depression

A

Dobutamine, Dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Medication for: Anaphylactic shock, cardiac arrest

A

Epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Medication for: fluid retention, left ventricular failure

A

Furosemide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Medication for: Hypoglycemia

A

Glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Medication for: hallucinations and psychotic states

A

Haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Medication for: Hypercoagulability

A

Heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Medication for cardiac arrhythmia

A

Magnesium sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Medication for Cerebral edema, fluid retention

A

Mannitol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Medication for hypoxia

A

Oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Medication for bronchoconstriction systemic/ inhaled

A

Salbutamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Medication for acidosis, some cardiac disturbances

A

Sodium bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Toxicological screen

A

Spot urine test, color test

Thin layer chromatography

  • rapid 2 to 4 hours
  • urine or plasma
  • not for volatiles, alcohols, metals, cyanide, salicylates

Gas and high-pressure chromatography

  • for any specimen
  • for confirmation

Mass spectrometry
-high specific/sensitive but expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

ICU admission criteria

A

Intubation when:
Ventil failure
Airway protection
Therapy induced hypocapnia/alkalosis

CNS: seizures, coma, GCS < 9

CVS: arrhythmia, AV block long QRS, hypotension

Large ingested dose: high blood levels = poor outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Drugs associated with SEIZURES:

A

P - Pesticides, Propoxyphene
L - Lead, Lithium, Lindane, Local anesthetics
A - Antidepressant, Anticonvulsants,
Antihistamines,Antipsychotics, Abstinence
S - Salicylates, Sympatomimetics, Strychnine, Solvents
T - Theophylline, Tricyclic antidepressants, Thallium, Tobacco(nicotine)
I - Insulin, Insecticides, INH
C - Camphor, Cocaine, Cyanide, Chloroquine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Odor: Acetone

A

Acetone, isopropanol,metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Odor: Airplane Glue

A

Toluene, aromatic hydrocarbon inhalation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Odor: alcohol

A

Ethanol ( no ethylene glycol or vodka)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Odor: Ammonia

A

Ammonia or Uremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Odor: bitter Almonds

A

Cyanide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Odor: Coal gas

A

Carbon monoxide = odorless but mix with illuminating gas for detection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Odor: Disinfectants

A

Phenol, Creosote

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Odor: Formaldehyde

A

Formaldehyde, Methanol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Odor: Garlic

A

Arsenic, Parathion, Yellow Phosphorus, Se, Zn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Odor: Pears

A

Chloral hydrate, Paraldehyde

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Odor: Rotten Eggs

A

Disulfiram, Hydrogen Sulfide, hepatic failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Odor: Shoe polish

A

Nitrobenzene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Anticholinergic syndromes

A

Cause:

antihistamines
antiparkinsonian
atropine
antipsychotic agents
antidepressant agents
mydriatic agents
skeletal muscle relaxants
Amanita muscaria

Common signs:

delirium with mumbling speech
incoordination and ataxia
respiratory failure
coma
tachycardia
hypertension
dry, flushed skin
dilated pupils
myoclonus
slightly elevated temperature
urinary retention
decreased bowel sounds
seizures
dysrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Sympathomimetic Syndromes

A

Cause:

cocaine
amphetamine
methamphetamine
ephedrine
pseudoephedrine
phenylpropanolamine

Common signs:

delusions
paranoia
tachycardia
hypertension
hyperpyrexia
diaphoresis
piloerection
mydriasis
hyperreflexia
seizures
hypotension
dysrhytmias – severe cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Cholinergic Syndromes

A

Cause:

organophosphate and carbamate insecticides
physostigmine
edrophonium
some mushrooms

Common signs:

confusion
central nervous system depression
weakness
salivation
lacrimation
urinary/fecal incontinence
gastrointestinal cramping
emesis
diaphoresis
muscle fasciculations
pulmonary edema
miosis
bradycardia / tachycardia
seizures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Opiate, Sedative or Ethanol Intoxication

A

Cause:

narcotics
barbiturates
benzodiazepines
ethchlorvynol
glutethimide
methyprylon
meprobamate
ethanol
clonidine

Common signs:

coma
respiratory depression
miosis
hypotension
bradycardia
hypothermia
pulmonary edema
decreased bowel sounds
hyporeflexia
seizures may occur  (propoxyphene)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Normal Anion Gap

A

3-11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

High Anion Gap induced by:

A
  • metabolic acidosis
  • dehydration / loss of fluid
  • infusions of salts of organic acids (lactate, acetate, citrate)
  • reduced unmeasured cations (K, Ca, Mg)
  • alkalemia
  • systematic underestimation of serum chloride
  • laboratory error
73
Q

Low Anion Gap induced by:

A
  • volume expansion with free water
  • systematic underestimation of serum sodium (hyperNa, hyperviscosity)
  • systematic overestimation of serum chloride
  • raised unmeasured cations
  • acidemia from a respiratory or hyperchloremic metabolic acidosis
  • laboratory error
74
Q

Osmolal Gap

A

M – C > 10 mOsm/kg H2O

laboratory error
decreased serum water content
↓M subst not used in equation

M normal and C ↓

decrease in serum water associated with
hyperproteinemias and hyperlipidemias

M↑ and C normal/↓ gap= unmeasured osmoles

sorbitol ethanol
mannitol methanol
glycerin ethylene glycol
isoniazid ether
diatrizoate sodium acetone
75
Q

Specific Antidote in (~5% acute poisonings):

A

NALOXONE + GLUCOSE 5%

Patients having CNS

76
Q

First priority:

A

Airways, Breathing

  • ventilation
  • oxygenation

Obstruction:
mucosa edema, secretions, foreign body,
defectuos position of tongue

Symptoms:
cyanosis, tahipneea, dyspnea, diaphoresis,
altered mental status

77
Q

Second Priority:

A

CIRCULATION

Shock: 
↓level of consciousness
↓BP
peripheral vasoconstriction
metabolic acidosis
oliguria

Mechanism:
↓contractility
hypovolemia
preload, afterload

78
Q

Third priority:

A

DISABILITY

CNS

  • pupils
  • coma

 IV Decontamination

79
Q

REED classification

A
Conscious level
Pain response
Reflex response
Respiration 
Circulation
\_\_\_\_\_\_\_\_\_\_
0 asleep arousable intact normal normal
I comatose withdraws intact normal normal
II comatose none intact normal normal
III comatose none absent normal normal
IV comatose none absent cyanosis shock
80
Q

Absorbtion prevention

A

Internal decontamination

Dilution: caustics, corrosive
-> 300ml milk or water

CI: neutralization reactions

81
Q

Emetics

A

 Ipecac syrup 10-30 ml, apomorphine,
pharyngeal stimulation

 Must have: awake patient with gag reflex

__________

Absolute contraindications:

  1. unprotected airway (altered mental status)
  2. strong acids/alkalis
  3. petroleum derivates
  4. children<6m
  5. seizures
  6. hematemesis
82
Q

Gastric lavage

A

 Saline solutions: 200-250 ml, 1min, drainage
 Useful early after ingestion 4-6h
 Doubtful efficacy after this but may be useful for slow absorbed agents

Indications:
\_\_\_\_\_\_\_\_\_\_\_
CI  emesis
analgesics
antidepressants
alcohols: meth, EG
others: digoxin, theophilline
Contraindications:
\_\_\_\_\_\_\_\_\_\_\_\_
strong acid/alkalis
petroleum derivates
bleeding
83
Q

Activated charcoal

A

 50-100 g immediately following lavage , then 50g q4h

Mechanism: adsorbtion !!!!

Repeted dose effctive for:        
\_\_\_\_\_\_\_\_\_\_\_\_\_\_
benzo, barbiturates
narcotics
tricyclics
phenothiazines
salicylates
digoxin
digitoxin
atropine
Inefective for:       
\_\_\_\_\_\_\_\_\_\_\_\_
most heavy metals
pesticides
cyanide
alcohol
strong acid/alkalis
Contraindications:  
\_\_\_\_\_\_\_\_\_\_\_\_
unprotected airway
strong acid/alkali
petroleum derivates
84
Q

Barbiturates

A
  • Hypnotic and sedative agents
  • Induction of anesthesia
  • Treatm of epilepsy

 Mechanism of toxic:

depression of neuronal activity
GABA mediated synaptic inhibition
depression of central sympathetic tone
↓ cardiac contractility

 Toxic dose:
(drug, route, rate, individual tolerance)

toxicity= 5-10 x hypnotic dose

 Clinical presentation:

A. lethargy, slurred speech, nystagmus, ataxia
hypotension, coma, resp arrest

B. Hypothermia - deep coma + hypotension/bradycardia

85
Q

Barbiturates Diagnosis

A

Diagnosis :

history of ingestion
epileptic patient with stupor or coma
skin bullae –no specific
serum level: 60-80 mg/l -> coma

electrolytes, glucose, ABG, BUN, creatinine

86
Q

Barbiturates Treatment

A

Treatment:

A. airway, assist ventilation
coma, hypotermia, hypotension

B. no specific antidote

C. Decontamination:

prehospital: activated charcoal, ipeca (min)
hospital: activated charcoal, gastric lavage

D. Enhanced elimination:

  1. alkalinization of the urine
  2. repeat-dose activated charcoal
  3. hemoperfusion
87
Q

Benzodiazepines

Mechanism of Toxicity:

A

GABA med synaptic inhibition

Inhib other neuronal syst
-> depression of spinal reflexes / RAS

88
Q

Benzodiazepines

Toxic dose:

A

Oral overdose:
Diazepam 15-20 x therap dose

Rapid iv - Respiratory arrest

89
Q

Benzodiazepines

Clinical:

A

lethargy, slurred speech, ataxia, coma, resp arrest
hyporeflexia, midposition or small pupils
hypothermia
complications ! short acting/other depressant

90
Q

Benzodiazepines

Diagnosis

A

History ingestion or injection
Dif Diagnosis
Reverse with Flumazenil

91
Q

Benzodiazepines

Treatment

A

A. Emergency and supportive measures:
airway, assist ventilation
coma, hypotermia, hypotension

B. Specific drugs and antidotes:
FLUMAZENIL iv 0,1 – 0,2 mg, repetead as
needed < 3mg

C. Decontamination:

prehospital: activated charcoal, ipeca (min)
hospital: activated charcoal, gastric lavage

D. Enhanced elimination:
no role for diuresis, dialysis, etc.

92
Q

Cyclic Antidepressants

Mechanism of toxicity

A

CV mechanism:

  1. anticholinergic effects => tachycardia , mild hypertension
  2. peripheral α adrenergic blockade =>vasodilation
  3. effect quinidinelike => myocardial depression, conduction disturbances

CNS mechanism:

  1. anticholinergic toxicity
  2. inh reuptake of norepinephrine/serotonin
  • relevant pharmacokinetics
    1. slow absorbtion
    2. active metabolites
    3. binding to body tissues and plasma proteins
93
Q

Cyclic Antidepressants

Toxic dose

A

Toxic dose:
narrow therapeutic index: intoxication

10-20 mg/kg potentially life-threatening

94
Q

Cyclic Antidepressants

Clinical

A

3 major syndromes:

A. Anticholinergic:
sedation, delirium, coma, dilated pupils, dry skin, ↓sweating, tachycardia, ↓ bowel sounds, urinary retention

B. Cardiovascular:
abnormal cardiac conduction, arrhythmias, hipotension

C. Seizures:
recurrent/ persistent hyperthermia, rhabdomyolysis, brain damage,multisystem failure, death

D. Death:
ventricular fibrillation, intractable, cardiogenic shock, status epilepticus with hyperthermia

95
Q

Cyclic Antidepressants

Diagnosis

A

Diagnosis

any patient with lethargy, coma, seizures,
QRS ↑

QRS ↑> 0,12 = severe poisoning

A. specific levels:
______
terapeutic c% = 300 ng/ml
serious poisoning = 1000 ng/ml or greater

B. other useful lab studies:
electrolytes, glucose, BUN, creatinine, cont EKG monitoring, x-ray, ABG

96
Q

CYCLIC ANTIDEPRESSANTS

Treatment

A

A. Emergency and supportive measures:

  1. airway and assist ventilation;
  2. coma, seizures, hyperthermia, hypotension, arrhythmias
  3. neuromuscular blocker
  4. continuos monitor Temperature, vital signs, ECG

B. Specific drugs and antidotes:

sodium bicarbonate 1-2 mEq/kg iv
-> pH 7.45-7.55

C. Decontamination

  1. prehospital : activated charcoal
    ! not emesis
  2. hospital : activated charcoal
    gastric lavage

D. Enhanced elimination :

dialysis/ hemoperfusion not efective

97
Q

PHENOTHIAZINES

Mechanism of toxicity

A

CV mechanism:

  1. anticholinergic effects => tachycardia, mild hypertension
  2. peripheral α adrenergic blockade => vasodilation => hypotension
  3. effect quinidinelike => myocardial depression, conduction disturbances

CNS mechanism:

  1. anticholinergic toxicity => CNS depression
  2. α adrenergic blockade => miosis
  3. central dopamine receptor blockade => extrapyramidal dystonic reactions
  4. distrubances of temperature regulation => poikilothermy
  5. low seizure threshold => mech unknown
98
Q

PHENOTHIAZINES

Toxic Dose

A

high toxic-therapeutic index

extrapiramidal reactions, anticholinergic side effects, orthostatic hypotension =>
therapeutic doses

99
Q

PHENOTHIAZINES

Clinical

A

A. Mild intoxication:
sedation, small pupils, orthostatic hypotension.
Aach manifestions:dry mouth, absence of sweating, tachycardia, urinary retention

B. Severe intoxication:
coma, seizures, respiratory arrest, QT ↑,
hypo/hyperthermia

C. Extrapyramidal distonic effects:
torticollis, jaw muscle spasm, rigidity, bradykinesia

D. Chronic => neuroleptic malignant syndrom: rigidity, hyperthermia, sweating, lactic acidosis, rhabdomyolysis

100
Q

PHENOTHIAZINES

Diagnosis

A

History of ingestion
sedation, small pupils, hBP, QT ↑

A. specific levels: Q not available, only qualitative

B. other useful lab studies: electrolytes, glucose, BUN, creatinine, CPK, cont EKG monitoring, chest and abdominal x-ray, ABG

101
Q

PHENOTHIAZINES

Treatment

A

A. Emergency and supportive measures:

  1. airway and assist ventilation; supplemental O2
  2. coma, seizures, hyperthermia, hypotension, arrhythmias
  3. continuos monitor Temp, vital signs, ECG

B. Specific drugs and antidotes:

no specific antidote

C. Decontamination

  1. prehospital : activated charcoal
  2. hospital : activated charcoal, gastric lavage ?

D. Enhanced elimination :

dialysis/ hemoperfusion not efective

102
Q

OPIOIDS

Mechanism of toxicity

A

*stimulates specific opiate receptors in CNS
=> sedation,
=> respiratory depression -> resp.failure -> apneea -> death

  • noncardiogenic pulmonary edema
103
Q

OPIOIDS

Toxic dose

A

Depend on:

compound, route, tolerance, rate of adm

104
Q

OPIOIDS

Clinical

A

A. mild/moderate overdose:
lethargy, small pupils (pinpoint size), TA↓,
flaccid muscles, bowel sounds ↓

B. higher dose:
respiratory depression, apnea, pulmonary edema

C. seizures: not common

105
Q

OPIOIDS

Diagnosis

A

pinponts pupils, respiratory and CNS depression

-> quickly awakens after adm of Naloxone

signs of iv drug abuse

Screening

Lab: electrolytes, glucose, ABG, x-ray

106
Q

Which iv injected drug can induce non-cardiogenic pulmonary edema and resp distress?

A

iv injected HEROIN

also salicylates and cocaine

107
Q

OPIOIDS

Complications

A
ARDS 
Aspiration pneumonia 
Lezional APE
Postinject venous thrombosis 
Necrosis after inject paravenous
Hepatitis B, C 
HIV
Abcess
Rabdomiolisis
Renal insuf
108
Q

Sindrom de intrerupere - OPIOIDS

A

INTENTIONALE (pentru obtinerea drogului)
la 6 – 8 ore DUPA INTRERUPERE
maxim : 36 – 72 ORE

NEINTENTIONALE la 8-12 ORE: ↑ 24 ORE ULTERIOR STABILE

LACRIMATIE, RINOREE, CASCAT, PERSPIRATIE
SOMN AGITAT, TREZIRE DEZAGREABILA
MIDRIAZA, ANOREXIE, AGITATIE, IRITABILITATE, TREMOR

Pentru MORFINA, HEROINA: max 36 – 48 ore
-> 72 ore
↓ 5 – 10 ZILE

MAXIM:
INSOMNIE, ANOREXIE INTENSA, AGITATIE EXTREMA, ANXIETATE, LACRIMATIE, RINOREE, DEPRESIE, GREATA, VOMA, SPASM INTESTINAL, DIAREE, TAHICARDIE, HTA, DURERI SI CRAMPE MUSCULARE, SCADERE IN GREUTATE, DESHIDRATARE, CETOZA, TULB. ACIDO-BAZICE

109
Q

Sindrom de intrerupere

Tratament

A

INSOMNIA: NITRAZEPAM, FLURAZEPAM, CLORALHIDRAT

ANXIETATEA: CLORDIAZEPOXID 10 mg x 4 / zi

CRAMPE DIGESTIVE: PROPANTELINA
PREPARAT DE BELLADONA

GREATA: PROCLORPERAZINA (METOCLOPRAMID)

PREVENIREA SINDR. DE ABSTINENTA:
CLONIDINA 0,1 mg x 3/zi

PREFERABIL INTRASPITALICESC

110
Q

ACETAMINOPHEN

Toxic dose

A

Toxic dose acute ingestion:

children > 140 mg/kg
adults > 6g; lethal 13-25 g

Rapid absorbtion: 1-4 h ; T1/2: 2-3 h

111
Q

ACETAMINOPHEN

Mechanism of toxicity

A

Mechanism of toxicity:

acetaminophen -P-450- toxic metabolit (hepatotoxic) NAPQI
-glutathione- detoxified
=liver injury

112
Q

ACETAMINOPHEN

Clinical

A

Clinical presentation
(depend upon the time after ingestion)

A. Early (0-24 h) - anorexia, nausea, vomiting , diaphoresis

B. After 24-48 h (latent) -transaminase level ↑
- PT ↑

C. Hepatic phase - acute hepatic failure -> encephalopathy -> death

D. Recovery phase: normalise hepatic tests (after 5 days)

113
Q

Acetaminophen

Diagnosis

A

Diagnosis

  • serum acetaminophen level
  • history

A. Specific levels : 4 h postingestion

B. Other useful lab studies: electrolytes, glucose, BUN, crea, transaminases, PT

114
Q

Acetaminophen

Treatment

A

Decontamination
1. prehospital : activated charcoal
emesis (4-6 h)
2. hospital : activated charcoal

Enhanced elimination :
hemoperfusion

Specific drugs and antidotes: N-acetylcysteine
140 mg/kg orally
70 mg/kg q4 h 17 doses

  • replates glutathion
  • adverse effects: vomiting
115
Q

SALICYLATES

Mechanism of toxicity

A

Mechanism of toxic:

► central stimulation of the respiratory center->
hyperventilation => respiratory alkalosis

► intracellular effects: Inhib of Krebs enzymes & uncoupling of oxidative phosphorylation
=> metabolic acidosis

► alteration in capillary integrity
► alteration of platelet function
► increase in glycolysis => hypoglycemia

116
Q

SALICYLATES

Toxic dose

A

Toxic dose:

therapeutic single dose 10 mg/kg

  • acute ingestion:
    150-200 mg/kg mild intoxication
    300-500 mg/kg severe intoxication
  • chronic intoxication:
    100mg/kg/d for 2 or more days
117
Q

SALICYLATES

Clinical

A

Clinical presentation

A. Acute ingestion:
vomiting, epigastric pain, hyperventilation, tinnitus, lethargy, respiratory alkalosis + metabolic acidosis
coma, seizures, hypoglycemia, hyperthermia,
dehydration, arrhythmias (K ↓)
pulmonary edema, CV collapse

B. Chronic intoxication:
confusion, dehydration, metabolic acidosis
mortality rates > acute ingestion
cerebral and pulmonary edema

118
Q

SALICYLATES

Diagnosis

A

history of acute ingestion
typical signs and symptoms

qualitative: colorimetric;

lab studies:
anion gap calculation, glucose, BUN, PT, ABG, chest X-ray

119
Q

SALICYLATES

Treatment

A

A. Emergency and supportive measures:
airway, assist ventilation, supplemental oxygen , X ray
coma, seizures, pulmonary edema, hyperthermia

metabolic acidosis: sodium bicarbonate 1-2 mEq
replace fluid and electrolyte deficits
monitoring

B. Specific drugs and antidotes: no antidote

C. Decontamination:

prehospital: activated charcoal, ipeca induced emesis (30 min)
hospital: activated charcoal, gastric lavage

D. enhanced elimination:
1. urinary alkalinization : sodium bicarbonate 
-> pH 7.5
alkalemia is not a CI
2. hemodialysis, hemoperfusion
3. repeat dose activated charcoal
120
Q

IZONIAZID

Mechanism of toxicity

A

Mechanism of toxicity:
PYRIDOXINKINASE
PYRIDOXINE PYRIDOXALPHOSPHAT

 Acute overdose: competition with pyridoxal 5-phosphate
↓ GABA
inh lactat>piruvat => lactic acidosis

 Peripheral neuritis

121
Q

IZONIAZID

Toxic dose

A

Toxic dose acute: min 1.5g

6g = severe toxicity => death

3mg/kg epileptics => status epilepticus

122
Q

IZONIAZID

Clinical

A

Clinical presentation

 slurred speech, ataxia, coma, seizures (30-60 min), metabolic acidosis, 
hemolysis
 tahicardia, cianosis, hTA, colaps
 oliguria -> anuria
 midriasis, nistagmus, 
 toxic psihosis, hyperpirexia
123
Q

IZONIAZID

Diagnosis

A

Diagnosis :

history of ingestion
clinical presentation

! Acute onset seizures + acidosis

124
Q

IZONIAZID

Treatment

A

Treatment

A. Emergency and supportive measures:
airway, assist ventilation
coma, seizures, metabolic acidosis (NAHCO

B. Specific drugs and antidotes: pyridoxine eq INH

C. Decontamination:

prehospital: activated charcoal, -> ! Not emesis
hospital: activated charcoal, gastric lavage

D. Enhanced elimination:
forced diuresis, dialysis

125
Q

IZONIAZID

Intoxication Outcome -> End Result

A

Blocking pyridoxinkinaza.

Hepatic necrosis

Tubular necrosis

Inh GABA => Metabolic Acidosis

126
Q

Classes of Pesticides

A
Insecticides (kill insects)
• Organochlorines
• Organophosphates
• Carbamates
• Synthetic Pyrethroids
Herbicides (kill plants)
Rodenticides (kill rodents)
Fungicides (kill fungus)
Fumigants (kill whatever)
127
Q

ORGANOPHOSPHATES

Mechanism of toxicity

A

A.inhibit acetylcholinesterase -> accumulation of acetylcholine
muscarinic R – cholinergic effector cells
nicotinic R – skeletal NM junctions, autonomic ganglia
CNS

B. Absorbtion:
inhalation
ingestion
skin contact

  • highly lipophilic
128
Q

ORGANOPHOSPHATES

Clinical

A

Toxic dose: wide spectrum, rate, metabolism

Clinical presentation: 1-2 h after exposure

M: vomiting, diarrhea, abd cramping, bronhospasm, miosis, bradycardia, salivation,
sweating -> dehydration -> shock

N: muscle fasciculations, tremor, weakness, resp muscle paralysis

CNS: agitation, seizures, coma, tremor
delayed peripheral neuropathy

129
Q

ORGANOPHOSPHATES

Diagnosis

A

Diagnosis:
history of exposure
characteristic sign
solvent odor

 Specific levels: ↓PChE, ↓AChE (more reliable)

130
Q

ORGANOPHOSPHATES

Classification

A

a. Latent poisoning:
Plasma chol activity >50%
No clinical manifestations

b. Mild poisoning:
Fatigue, headache, dizziness
N,V,D, abd cramps
Sweating, salivation
Plasma chol activity 20-50%

-> Atropine 1mg sc, good prognosis !!!

c. Moderate poisoning:
Miosis, fasciculations
Generalized weakness, unable to walk, difficulty speaking
Plasma chol activity 20-50%

-> Atropine 1-5mg iv q5min

d. Severe poisoning:
Miosis, fasciculations, coma, flaccid paralysis, no light reflex, profuse sweating, salivation,
bronchorrhea,
Plasma chol activitity Atropine 1-5 mg iv q5min

fatal if untreated !!!!!!

131
Q

ORGANOPHOSPHATES

Treatment

A

A. Emergency and supportive measures:
airway, assist ventilation, ! sudden resp arrest
coma, seizures, 6-8 h observation

B. Specific drugs and antidotes:
ATROPINE, PRALIDOXIME

atropine: 0.5-2 mg iv, repeated (persistent wheezing, bronchorrhea) , HR>60 bpm

pralidoxime: regenerate enzyme activity
1-2 g iv bolus, cont infusion, most effective first 24 h

C. Decontamination: 
skin: remove, wash exposed areas
ingestion:  
preH: activated charcoal, ipeca
H: activated charcoal, cathartic , gastric lavage

D. Enhanced elimination:
dialysis/ hemoperfusion not generally indicated

132
Q

ETHANOL

Mechanism of toxicity

A

A. CNS depression
additive effect
B. hypoglycemia
C. predisposition to trauma, hypothermia, metab derangements

133
Q

ETHANOL

Toxic dose

A

Toxic dose: 5-8 g/kg

Individual degree of tolerance:
300 mg/dl coma for novice drinkers
500 – 600 mg/dl awakeness – chronic alcoholics

Absorbtion:
20% stomach; 80% intestin

usual 30-60 min (80-90%)
food delayed abs 4-6 h

134
Q

ETHANOL

Clinical

A

Clinical presentation:
sensitivity: frontal> occipital> cerebellum

*moderate intoxication:
euphoria, mild incoordination, ataxia, nystagmus, impaired
judgment and reflexes, aggressive behavior, hypoglycemia

  • deep intoxication:
    coma, respiratory depression, pulmonary aspiration, TA↓,
    small pupils , HR↓
  • alcohol withdrawal
  • tremulousness, anxiety, SNS overactivity, convulsions -> delirium
  • other problems
  • substitutes ingestion
135
Q

ETHANOL

Diagnosis

A

history of ingestion
smell
nistagmus, ataxia, altered mental status, hypoglicemia

may acompany : head trauma, meningitis, hypothermia

other drug intoxication
rough correlation blood levels – clinical presentation
other lab studies

136
Q

ETHANOL

Treatment

A

A. Emergency and supportive measures:
airway (prevent aspiration), intubate, assist ventilation
glucose, thiamine, treat coma, seizures,
corect hypothermia with gradual rewarming

B. Specific drugs and antidotes: no antidote

C. Decontamination:
ipeca, gastric lavage not indicated

prehospital: ipeca (min)
hospital: gastric lavage (30 min), activated charcoal if + other toxin

D. enhanced elimination:
hemodialysis (rarely needed)
hemoperfusion, forced diuresis not effective

137
Q

ETHANOL

Antidote for poisoning by:

A

Methanol
Ethylene glycol
Diethylene glycol

- Inhibits metabolic activation by 
alcohol dehydrogenase (ADH)
138
Q

Alcohol withdrawal effects

A
  • Tremor
  • Nausea
  • Irritability
  • Agitation
  • Tachycardia
  • Hypertension
  • Seizures
  • Hallucinations
139
Q

METHANOL

Mechanism of toxicity & Toxic dose

A

Mechanism of toxicity:

methanol -> formaldehyde -> formic acid (systemic acidosis) formate -> blindness

Toxic dose:
fatal min oral dose: 30 ml 40%
10 ml sol 40% - blindness

140
Q

METHANOL

Clinical

A

A. first few hours:
inebriation, gastritis, not acidosis, ↑OG

B. after a latent period (up to 30h):
severe metabolic acidosis,
visual disturbances, blindness, seizures, coma, death

visual disturbances: “ like standing in a snowfield”

fundoscopic exam:
optic disk hyperemia, venous engorgement,
papilledema

141
Q

METHANOL

Diagnosis

A

history of ingestion
symptoms
lab findings, AG, OG

a. Specific levels:
serum methanol > 20 mg/dl =toxic latent period

Elevated serum formate: better measure of toxicity

b. Other useful lab studies:
electrolytes, glucose, BUN, creatinine, serum osmolality, osmolar gap, ABG, lactate level

142
Q

METHANOL

Treatment

A

A. Emergency and supportive measures:
airway , intubate, assist ventilation
treat coma, seizures
metabolic acidosis : SODIUM BICARBONATE

B. Specific drugs and antidotes:
ETHANOL
history of significant methanol ingestion, OG>5mosm/l
metabolic acidosis,
methanol c% >20 mg/dl -> c% ethanol 100-150 mg%

FOLIC ACID enhance formate -> CO2 + water ; 50mg iv q4h

4-METHYLPYRAZOLE – INH adh, experimental

C. Decontamination:
preH: ipeca,
H: gastric lavage , activated charcoal = not efficiently

D. enhanced elimination:
hemodialysis , τ↓ 3-6 h
ind: methanol poisoning with significant metabolic acidosis
OG>10mosm/l

143
Q

ETHYLENE GLYCOL

Mechanism of toxicity & toxic dose

A

Ethylene glycol -> glycoaldehyde
glycolic / glyoxylic / oxalic acids -> metab acidosis

Oxalate + Ca -> calcium oxalate crystals (insoluble) -> tissue injury

Toxic dose: 100 ml

144
Q

ETHYLENE GLYCOL

Clinical

A
  1. first 3-4 h:
    ≈ethanol, OG↑, no acidosis; gastritis with vomiting
  2. after 4-12 h:
    anion gap acidosis, hyperventilation, convulsions, coma, cardiac conduction disturbances, arrhythmias, renal failure (reversible), pulmonary /cerebral edema, hCa
145
Q

ETHYLENE GLYCOL

Diagnosis

A

history of antifreeze ingestion
typical symptoms, OG ↑, AG ↑
oxalate crystals (urine)
ethylene glycol level

50 mg/dl -> serious intoxications

Other lab studies:
electrolytes, glucose, BUN, creatinine, calcium,
transaminases,osmolality, ABG, ECG

146
Q

ETHYLENE GLYCOL

Treatment

A

A. Emergency and supportive measures:
airway ,intubate, assist ventilation
treat coma, seizures, cardiac arrhytmias, metabolic acidosis
-> treat hypocalcemia: CALCIUM GLUCONATE iv

B. Specific drugs and antidotes: ETHANOL

(prevent metabolism of EG to its toxic metabolites: pyridoxine, folate, thiamine)

C. Decontamination:
ipeca, gastric lavage not indicated
prehospital: ipeca (min)
hospital: gastric lavage (30 min), activated charcoal not efficiently

D. enhanced elimination:
hemodialysis ind: OG>10 mosm/l, intoxication+renal failure
c%>20 – 50 mg/dl

147
Q

HYDROCARBONS

Mechanism of toxicity & toxic dose

A

Used: petroleum, plastic, agricultural chemical
industries as solvents, degreasers, fuels, pesticides

Mechanism of toxic:

  • pulmonary aspiration
  • sistemic intox: ingestion, inhalation, skin absorbtion
  • simple petroleum distillates: poorly absorbed
  • aromatic / halogenated HC, alcohols, ethers,ketones: serious systemic toxicity

Toxic dose:
pulmonary aspiration: few ml -> chemical pneumonitis

ingestion: 10-20 ml (camphor, CCl4)

148
Q

HYDROCARBONS

Clinical

A

A. pulmonary aspiration:
coughing, choking, gagging, tachipneea, wheezing, severe chemical pneumonitis, sec bacterial infection, respiratory complications

B. ingestion:
abrupt nausea, vomiting, hemorrhagic gastroenteritis

C. systemic toxicity:
confusion, ataxia, lethargy, headache, syncope, coma, respiratory arrest, cardiac arrhythmias

D. skin/eye contact:
irritation, burns, corneal injury

149
Q

HYDROCARBONS

Diagnosis

A

A. aspiration :
history of exposure, respiratory symptoms ,<4-6h
chest X-ray, ABG

B. systemic intoxication:
history of ingestions/inhalation
systemic clinical manifestation

Specific level: not available

150
Q

HYDROCARBONS

Treatment

A
A. Emergency and supportive measures:
1. general: 
BLS for all symptomatic patients
airway , supplemental O2, assist ventilation
monitor ABG, chest X-ray, ECG
  1. pulm aspiration:
    observation 4-6 h
    coughing on arrival= aspiration
    ! Do not use steroids !
  2. ingestion: 5-10 ml – systemic toxicity rare

B. Specific drugs and antidotes: no specific antidote
(acetylcysteine –CCl4,)

C. Decontamination:
Inh: move the victim to fresh air, O2
Skin /eyes: remove, wash

Ingestions: do not induse emesis, activated charcoal, cathartic

D. Enhanced elimination: no role

151
Q

HYDROGEN SULFIDE

Mechanism of toxicity & toxic dose

A

= Highly toxic, flammable, colorless gas, heavier than air
• industrial processes, petroleum, mines, carbon disulfide production, hot asphalt

Mechanism of toxic:

inh cytocrom oxidase system -> cellular asphyxia
rapidly absorbed -> symptoms immediately
= mucous membrane irritant

Toxic dose:   
•rotten egg odor=0.025ppm
•recomm workplace limit=10ppm
•resp tract irritation, olfactory nerve paralysis =50-100 ppm 
•dangerous for life =300 ppm
•fatal= 600-800 ppm
152
Q

HYDROGEN SULFIDE

Clinical

A

A. irritant effect:
upper airway irritation, burning eyes, blepharospasm;
skin exposure: painful dermatitis, pneumonitis, noncardiogenic pulmonary edema

B. Acute systemic effect:
headache, nausea, vomiting, dizziness,
confusion, seizures, coma

-> massive exposure: immediate CV collapse, respiratory arrest, death

153
Q

HYDROGEN SULFIDE

Diagnosis

A

Diagnostic:

hystory of exposure
progressive airway irritation and cellular asphyxia

smell: rotten eggs ‼️

N. olfact. Paralysis
serum levels : not available

154
Q

HYDROGEN SULFIDE

Treatment

A

A. Emergency and supportive measures:
airway , high-flow humidified O2, assist ventilation
treat coma, seizures, hypotension
corect hypothermia with gradual rewarming

B. Specific drugs and antidotes:
nitrites -> methemoglobinemia: sulfide
ion -> sulfhemoglobin (less toxic)

C. Decontamination:
remove from exposure, supplem O2

D. enhanced elimination: no role
hyperbaric oxigen therapy: no scientific evidence

155
Q

CARBON MONOXIDE

Mechanism of toxicity + Toxic dose & Sources

A

SOURCES:

  • smoke inhalation in fires
  • auto exhaust fumes
  • poorly or faulty ventilated charcoal
  • kerosene, cigarette smoke

• Mechanism of toxic:
cellular hypoxia and ischemia

► CO affinity= 250 x O2 curve
► inhibit cytochrom oxidase SaO2↓

• T1/2 COHb = 3 – 4 h IN ATMOSPERIC air
= 30 – 40 min ATMOSFERA O2 100%
= 15 – 20 min O2 HIPERBARR (2,5 ATM)

► sensitivity of the brain
► Hb F fetal=2 x maternal levels

• Toxic dose:
limit accepted = 25ppm
dangerous = 1500 ppm (0.15%)
mins 1000 ppm SaCO 50%

156
Q

CARBON MONOXIDE

Clinical

A

Clinical presentation: brain and heart

A. Headache, dizziness, nausea / angina, myocardial infarction, impaired thinking, syncope, coma, convulsions, cardiac arrhythmias, hipotension,
=> death

Concentration | COHb | Symptoms
ppm % :

< 35 | 5 
none, mild headache
50 | 10           
slight headache, dyspnea on vigorous exertion
100 | 20 
throbbing headache, dyspnea with moderate exertion
200 | 30           
severe headache, irritability, fatigue
300-500 | 40-50       
headache, tachycardia, confusion, lethargy, collapse
800-1200 | 60-70       
coma, convulsion
1900 | 80             
rapidly fatal

B. Neurologic sequelae :
parkinson, persistent vegetative state,
personality and memory disorders

C. Pregnancy -> fetal death

157
Q

CARBON MONOXIDE

Diagnosis

A
Diagnosis 
– history of exposure,
- no specific findings
- cherry red skin coloration + bright red venous blood
- ABG, pulse oximetry

A. Specific levels: CoHb

B. lab studies:
electrolytes, glucose, BUN, creatinine, ECG

158
Q

CARBON MONOXIDE

Treatment

A

• Treatment

A. Emergency and supportive measures:
airway, assist ventilation, early intubation if smoke inhalation
coma, seizures
monitoring EKG

B. Specific drugs and antidotes: OXIGEN (100%) ↓τ C

C. Decontamination:
remove from exposure / suppl O2

D. Enhanced elimination:

HYPERBARIC OXYGEN 100% -> 2-3 atm ‼️

159
Q

CYANIDE

Source & Toxic dose

A
• Sources: 
-industry, chemical lab, plants
- burns: polyurethane,
polyacrylonitryl, silk, wool -
drugs: nitroprusside
• Toxic dose:
– INHALED: 100 ppm (in 1 hour)
300 ppm MINUTE
– INGESTED: 50 mg LETAL (HCN)
200- 300 mg KCN
  • ABSORBTION : rapidly
  • ELIMINATION : metabolic
160
Q

CYANIDE

Mechanism of toxicity

A

• Mechanism:

CN-(+ Fe3+) blocks cytochrome oxidase -> impairing oxidative phosphorylation, anaerobic metabolism, lactic acid generation -> metabolic acidosis

161
Q

CYANIDE

Clinical

A

CLINIC:
– coma, convulsions -> metabolic acidosis -> shock -> respiratory failure -> DEATH (few min)

– Early effects:
cellular hypoxia -> headache,anxiety, tachycardia, hyperpnea, mild HTA, palpitations
– Later effects:
nausea, vomiting,tachi/bradi, hTA, seizures,
coma, apneea, mydriasis, cardiac dysrhytmias, heart blocks, asystole

! Absence of cyanosis sugests CN-

162
Q

CYANIDE

Diagnosis

A

DIAGNOSTIC:

severe metabolic acidosis
red venous blood
bitter almond odor ‼️ <- typical
coma with rapidly onset, 
‼️ absence of Cyanosis
tachypnea
163
Q

CYANIDE

Treatment

A

• SUPPORTIVE TREATM:

  • assisted ventilation, OXYGEN 100%
  • correct acidosis

• DECONTAMINATION:

  • AFTER ANTIDOTE ADM !
  • < 2h: Lavage, ACTIVATED CHARCOAL

• ENHANCE ELIM

  • HEMODIALYSIS, HEMOPERFUSION – NO ❌
  • HYPERBARIC O2

ANTIDOTES:
‼️NITRITES →Methaemoglobinemia

MeHb-Fe3+ +CN-CITOCROMOXIDAZA →MeHb-CN + CITOCROMOXIDAZA

METHEMOGLOBINE →40%
___________

  • AMYL NITRITE - FIRST EMERGENCY‼️‼️
  • SODIUM NITRITE 3% 10 ml i.v. SLOW (~ 20% MeHb)

• THIOSULFATE: sol. 25% 50 ml i.v. SLOW;
Repeted cca. 1 h NITRITE + THIOSULFATE - half doses

  • HYDROXYCOBALAMIN
  • CoEDTA (KELOCYANOR)
  • monitoring 2 – 3 days
  • MeHb 40%
  • TREAT ACIDOSIS !!!
164
Q

IRON

Mechanism of toxicity & toxic dose

A

• Mechanism of toxicity:

  1. direct corrosive effect -> hemorrhagic necrosis /perforation
  2. absorbed iron => cellular dysfunction -> lactic acidosis and necrosis

• Toxic dose:

acute lethal dose 150-200 mg/kg ❗️
lowest LD 600 mg
20-30 mg/kg -> vomiting, abd pain, diarrhea
> 60 mg/kg = potentially lethal

165
Q

IRON

A

• Clinical presentation:

A. shortly after ingestion: vomiting, diarrhea (bloody)
massive fluid loss -> shock, renal failure, -> death

B. apparent improvement over 12 hours

C. coma, shock, seizures, coagulophaty, hepatic failure, YE sepsis, death

D. pyloric stricture, other intestinal obstruction

• Diagnosis:
history of exposure
vomiting
diarrhea
hTA
L↑
Gluc↑>150 mg/dl
166
Q

IRON

Treatment

A

A. Emergency and supportive measures:
airway, assist ventilation, hypovolemia, shock
coma, seizures, metabolic acidosis

B. Specific drugs and antidotes: DEFEROXAMINE ‼️

pink red color = chelated deferoxamine-iron complex

C. Decontamination:

prehospital: ipeca –emesis
hospital: emesis, gastric lavage, x-ray

❌activated charcoal does NOT adsorb iron‼️

D. Enhanced elimination:
hemodyalisis, hemoperfusion not effective

167
Q

ARSENIC

Mechanism of toxicity & Toxic dose

A

Mechanism of toxic:

interacting with sulfhydryl groups (trivalent)
substituting for phosphate (pentavalent)

A. soluble comp. – greatest risk
B. inorganic dusts – skin, mucous memb., resp and GIT
C. human carcinogen

• Toxic dose:

A.inorganic      
acute 100-300 mg As+3
chronic 20-60 μg/kg/d
B. organic          
less toxic  - marine organisms
168
Q

ARSENIC

Clinical

A

Clinical presentation

A. acute exposure:

  1. GIT effects: nausea, vomiting, abd pain, watery diarrhea
  2. cardiopulm effects: congestive cardiomyopathy, pulm edema, ↑QT
  3. neurologic effects: delirium, encephalopathy, coma
  4. others: Aldrich-Mees lines, hair loss, leukopenia

B. chronic intoxication:

fatigue, gastroenteritis, anemia, leukopenia

  1. skin lesions
  2. cancer – chronic inhalation -> lung cancer
    - chronic ingestion ->lung, liver, kidney, bladder
169
Q

ARSENIC

Diagnosis

A

Diagnosis:

history of exposure + typical presentation

garlic odor ‼️

X-ray
specific levels : n <1 ppm

170
Q

ARSENIC

Treatment

A

A. Emergency and supportive measures:
airway, assist ventilation
coma, shock, arrythmias, hypotension

B. Specific drugs and antidotes:
BAL (DIMERCAPROL‼️) 3-5 mg/kg/im 4-6 h

C. Decontamination:

prehospital: activated charcoal, ipeca (min)
hospital: activated charcoal, gastric lavage

D. enhanced elimination:
hemodialysis

171
Q

LEAD

What is it ?

A

Lead acetate (Pb (C2H3 O2)2· 3H2O)
• White, crystalline substance
• Sugar of lead has a sweet taste
• Paint

Lead tetraethyl (Pb(C2H 5)4)
• antiknock compound added to gasoline
• air pollution

172
Q

LEAD

Mechanism of toxicity

A

Mechanisms Of Lead Toxicity

  • Inhibition of enzymatic processes
  • Lead-Calcium Interactions
  • Lead-Protein Interactions
  • Lead-Dopamine Interactions
  • Lead-Opioid Interactions
173
Q

LEAD

Health effects

A

Health Effects

  • Encephalopathy
  • Colic
  • Frank Anemia
  • Hemoglobin Synthesis
  • Peripheral Neuropathies
  • Infertility (MEN)
  • Systolic Blood Pressure (MEN)
  • Nerve Conduction Velocity
  • Erythrocyte Protoporphyrin
  • DEVELOPMENTAL TOXICITY❗️
  • IQ, Memory, Learning
  • Growth
174
Q

LEAD

Half life

A
  • 25 DAYS – BLOOD
  • 40 DAYS – SOFT TISSUE
  • 20 YEARS – BONE
175
Q

LEAD

Clinical

A

A.acute ingestion:
abdominal pain, anemia, toxic hepatitis

B.chronic intox:
fatigue, irritability, anorexia, insomnia, weight loss, arthralgias, myalgias, hypertension

-GI: nausea, constipation/diarrhea, crampy abd pain (lead colic)

-CNS: impaired concentration, headache, ↓ visual-motor coordination, ataxia, delirium,
convulsion, coma, ↓ intelligence, decreased growth

  • peripheral motor neuropathy: upper extremities, extensor muscle weakness
  • hematologic: anemia (normochromic,microcytic), hemolysis

-nephrotoxic: acute tubular dysfunction, (Fanconi-like aminoaciduria),
chronic interstitial fibrosis, hyperuricemia

-adverse reproductive outcomes: aberrant sperm production, decreased gestational age

176
Q

LEAD

Diagnosis

A

Diagnosis: symtomatology

– multisystem findings: abd pain, headache,
anemia
– child with: delirium, convulsions, neurobehevioral deficits
– whole blood level
– Urinary lead excretion; n<50 microg/d

177
Q

LEAD

Treatment

A

A. Emergency and supportive measures:
treat seizures, coma, adequate fluids (avoid overhydration) increased ICP -> corticosteroids

B. Specific drugs and antidotes: CHELATORS

encephalopathy: CALCIUM EDTA

C. Decontamination:
ipeca (min) ,gastric lavage , activated charcoal, cathartics

D. enhanced elimination:
no role

178
Q

ETHANOL METABOLISM

Which enzyme transforms Ethanol in Acetaldehyde?

A

ADH – Alcohol Dehydrogenase

179
Q

ETHANOL METABOLISM

Which Enzyme transforms Acetaldehyde in Acetate?

A

ALDH – Acetaldehyde Dehydrogenase

180
Q

Antidote for Methanol, Ethylene Glycol

A

Ethanol

181
Q

Antidote for LEAD

A

Edetate calcium disodium CaNa2-EDTA